Abstract
Two isostructural hydrazide–hydrazone-based complexes, namely [Zn(L)(HL)(ClO4)]·H2O and [Ni(L)(HL)(ClO4)]·H2O (HL = 2-acetylpyridine isonicotinohydrazone), have been obtained and characterized by physicochemical and spectroscopic methods. In each complex, the first ligand is in the neutral keto form, while the second is in the deprotonated monoanionic enolate form. Both complexes have excellent antitumor activity toward A549 human lung cancer, and BGC823 and SGC7901 human gastric cancer cell lines. Furthermore, both complexes are active scavengers for O 2 −· and OH·, exerting superior activities compared to the free ligand.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.